Literature DB >> 11211893

Bacterial translocation: cause or consequence of decompensation in cirrhosis?

G García-Tsao.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11211893     DOI： 10.1016/s0168-8278(00)00006-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  13 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

Review 2.  Infection, coagulation, and variceal bleeding in cirrhosis.

Authors:  U Thalheimer; C K Triantos; D N Samonakis; D Patch; A K Burroughs
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 3.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

4.  Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.

Authors:  Rubén Francés; José M González-Navajas; Pedro Zapater; Carlos Muñoz; Rocío Caño; Sonia Pascual; Dorkas Márquez; Francia Santana; Miguel Pérez-Mateo; José Such
Journal:  J Clin Immunol       Date:  2007-04-03       Impact factor: 8.317

5.  Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.

Authors:  J S Bajaj; S M Ratliff; D M Heuman; K L Lapane
Journal:  Aliment Pharmacol Ther       Date:  2012-11       Impact factor: 8.171

Review 6.  Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.

Authors:  HongQun Liu; Seyed Ali Gaskari; Samuel S Lee
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

Review 7.  Cardiovascular changes in cirrhosis: pathogenesis and clinical implications.

Authors:  Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

8.  Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis.

Authors:  Isabel Gómez-Hurtado; Arlette Santacruz; Gloria Peiró; Pedro Zapater; Ana Gutiérrez; Miguel Pérez-Mateo; Yolanda Sanz; Rubén Francés
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

Review 9.  Cardiovascular dysfunction in patients with liver cirrhosis.

Authors:  Giuseppe Fede; Graziella Privitera; Tania Tomaselli; Luisa Spadaro; Francesco Purrello
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar

10.  Beta-adrenergic receptor 1 selective antagonism inhibits norepinephrine-mediated TNF-alpha downregulation in experimental liver cirrhosis.

Authors:  Pedro Zapater; Isabel Gómez-Hurtado; Gloria Peiró; José Manuel González-Navajas; Irma García; Paula Giménez; Alba Moratalla; José Such; Rubén Francés
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.